The EU Commission publishes its second report on the monitoring of patent settlements in the pharmaceutical sector

Accardo, Gabriele

Previous article The US FTC issues a report on authorized generic drugs expressing concern that they are being used to delay generic competition Next article The EU Court of Justice AG Kokott proposes that the Court should set aside the ruling of the General Court and declare that the pay-for-delay agreements concluded by a pharmaceutical firm constituted an abuse of dominance (Servier)

5 Jul 2010

The EU Commission publishes its second report on the monitoring of patent settlements in the pharmaceutical sector

KEYWORDS

Reference

EU Commission, Commission welcomes decrease of potentially problematic patent settlements in EU pharma sector, Press release, IP/10/887, 5 July 2010

European Commission report shows decrease of potentially problematic patent settlements* On 5 July 2010, the Commission published its second report on the monitoring of patent settlements in the pharmaceutical sector. The report shows that the number of patent settlements that may fall afoul the EU antitrust rules decreased to 10% of

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Gabriele Accardo
Ashurst (Milan)

Italy 102 contributions 28483 visits

Quotation

Gabriele Accardo, The EU Commission publishes its second report on the monitoring of patent settlements in the pharmaceutical sector, 5 July 2010, e-Competitions Pay-for-delay agreements, Art. N° 62378

Visites 237